Glycogen Storage Disease Type II - 32 Studies Found
Completed |
: A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease :
|
Completed |
: An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease :
|
Completed |
: A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II :
|
Recruiting |
: NeoGAA Extension Study : Glycogen Storage Disease Type II Pompe Disease : 2013-12-04 : Drug: GZ402666 Pharmaceutical form:lyophilized powder reconstituted for infusion Route of administration |
Completed |
: Newborn Screening Assay of Pompe's Disease : Pompe Disease : 2008-07-09 : Other: Pompe disease newborn screening DBS will be tested for acid alpha-glucosidase (GAA)activity. Newb |
Recruiting |
: Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease :
|
Terminated |
: Study to Evaluate the Safety of AT2220 in Pompe Disease : Pompe Disease : 2008-05-30 :
|
Completed |
: Safety and Efficacy of Clenbuterol on Motor Function in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy : Pompe Disease : 2013-09-11 :
|
Recruiting |
: A Long Term Follow up Study in Late-onset Pompe Disease : Pompe Disease : 2008-07-09 |
Recruiting |
: A Pilot Study of Pyridostigmine in Pompe Disease : Pompe Disease : 2015-01-23 : Drug: Pyridostigmine Bromide Pyridostigmine is an acetylcholinesterase inhibitor, which increases the am |